Category: FSP

Moderna Completes Enrollment of Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273)

Why PPD’s Global Clinical Supply Functional Service is the Right Choice to Navigate Your Trials Through Brexit

Strategically Selecting the Right Outsourcing Model for Drug Development — Considerations for Emerging Biotech

Using Technology to Overcome Resourcing Challenges

Moderna Announces Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273) Begins

Regulatory Affairs: Mitigating COVID-19’s Impact on Clinical Trials

Successful Partnering in Pharmacovigilance For Clinical Trials

Reinforcing A Shared Mindset With Our Clients At PPD Biotech University

Outsourcing from a Pharmacovigilance Perspective